dementia | CARLAT PUBLISHING

How to Treat and Assess Delirium in Older Patients

December 26, 2022

Treatment of delirium involves correction of the underlying medical disturbance. But how do we best think through potential causes?

RESEARCH UPDATE

Can Pimavanserin Treat Psychosis in Patients With Dementia?

October 1, 2022

James Black, MD

James Black, MD. Dr. Black, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study suggests that patients started on pimavanserin for dementia and psychosis should probably continue it to prevent relapse, but we will need more data for clarity given flaws in the study design.

RESEARCH UPDATE

Trazodone Probably Not Effective for Dementia

October 1, 2022

Susan L. Siegfreid, MD

Susan L. Siegfreid, MD. Dr. Siegfreid, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study revealed no signal that trazodone protects against neurodegeneration.

CLINICAL UPDATE

Low-Dose Lithium to Delay Dementia?

September 1, 2022

Jim Phelps, MD

James Phelps, MD. Psychiatrist Emeritus, Samaritan Mental Health, Corvallis, OR. Medical Director, PsychEducation.org. Dr. Phelps, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Current medications for dementia do little more than temporarily slow the cognitive decline, but new evidence suggests that tiny doses of lithium can significantly delay the onset.

How to Interview the Older Patient

August 29, 2022

Stephanie Collier, MD and Rehan Aziz, MD.

The expanding population of older adults has created a need for all clinicians to participate in their care. Interviewing techniques require adaptation in older adults, such as accounting for hearing or vision impairment and speaking slowly and clearly. This podcast will cover additional factors to consider when evaluating older patients.

Annual Flu Vaccines

July 1, 2022

Thomas Jordan, MD

Thomas Jordan, MD. Dr. Jordan, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Although there is an association between influenza vaccinations and a lower dementia risk, association is not causation.

Assessing and Treating Delirium in Older Adults

July 1, 2022

Rehan Aziz, MD.

Rehan Aziz, MD. Associate program director, Geriatric Psychiatry Fellowship Program, Jersey Shore University Medical Center; associate professor of psychiatry and behavioral science, Hackensack Meridian School of Medicine, Edison, NJ. Dr. Aziz, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Treatment of delirium involves correction of the underlying medical disturbance. But how do we best think through potential causes? Dr. Aziz shares his systematic approach and clinical pearls in conducting a physical exam and ordering the appropriate work-up.

CLINICAL UPDATE

The 3 Ds of Geriatric Psychiatry: Depression, Delirium, and Dementia

July 1, 2022

Rachel Meyen, MD

Rachel Meyen, MD. Outpatient geriatric psychiatrist, General Mental Health Clinic, Sacramento VA Medical Center, Mather, CA. Dr. Meyen, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Symptoms of dementia, delirium, and depression in older adults may overlap, and these disorders often occur simultaneously. We learn how to disentangle these three illnesses through screeners and medical work-up, and how to optimize their management.

How to Interview the Older Patient

January 1, 2022

Rehan Aziz, MD. Inpatient geriatric psychiatry, Hackensack-Meridian Health, Perth Amboy, NJ. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The expanding population of older adults has created a need for all clinicians to participate in their care. Interviewing techniques require adaptation in older adults, such as accounting for hearing or vision impairment and speaking slowly and clearly. This article will cover additional factors to consider when evaluating older patients.

In the News: Aducanumab (Aduhelm)

November 5, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate professor of psychiatry and neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When the FDA approved aducanumab (Aduhelm) in Alzheimer dementia, the decision came with a heavy dose of controversy. Rehaz Aziz, MD, considers where this novel therapy fits in practice.